EFFICACY AND SAFETY OF S.C. INFLIXIMAB IN PATIENTS SWITCHED FROM I.V. FORMULATION OF INFLIXIMAB

NCT05719389 · clinicaltrials.gov ↗

UNKNOWN

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases
Rheumatologic Disease

Interventions

DRUG: CT-P13

Sponsor

IRCCS San Raffaele